This is a single
speech (house debate) resource
from the openparliament.ca API. If you’re new here, you might want to look at the documentation. If API and JSON are gibberish to you, you’re better off at our main site.
This is a single
speech (house debate) resource
from the openparliament.ca API. If you’re new here, you might want to look at the documentation. If API and JSON are gibberish to you, you’re better off at our main site.
{
"time": "2022-11-21 15:20:00",
"attribution": {
"en": "Mr. Stephen Ellis",
"fr": "M. Stephen Ellis"
},
"content": {
"en": "<p data-HoCid=\"7438232\">With regard to Health Canada's position on the practice of repackaging single use medications to treat macular degeneration, since 2016: (a) does Health Canada allow the practice; (b) what risks does Health Canada recognize as existing with the practice; (c) has Health Canada studied the risks associated with the practice related to (i) sterility, (ii) cold chain protection, (iii) ultraviolet light protection, (iv) accurate dosing, (v) contamination, (vi) transportation issues, and, if so, what were the findings related to each risk; (d) has Health Canada or the Minister of Health received any warnings or correspondence indicating or suggesting that the practice is occurring in Canada, and, if so, what are the details, including the (i) date, (ii) author of the warning or correspondence, (iii) summary of warning or correspondence, (iv) recipient, (v) summary of response given by Health Canada or the Minister's office; and (e) for each warning or correspondence that was received in (d), what follow-up action was taken?</p>",
"fr": "<p data-HoCid=\"7438232\">En ce qui concerne la position de Sant\u00e9 Canada sur la pratique du r\u00e9emballage de m\u00e9dicaments \u00e0 usage unique pour traiter la d\u00e9g\u00e9n\u00e9rescence maculaire, depuis 2016: a) Sant\u00e9 Canada autorise-t-il cette pratique; b) quels risques associ\u00e9s \u00e0 cette pratique Sant\u00e9 Canada reconna\u00eet-il; c) Sant\u00e9 Canada a-t-il \u00e9tudi\u00e9 les risques associ\u00e9s \u00e0 cette pratique en ce qui a trait (i) \u00e0 la st\u00e9rilit\u00e9, (ii) \u00e0 la protection de la cha\u00eene du froid, (iii) \u00e0 la protection contre les rayons ultraviolets, (iv) au dosage pr\u00e9cis, (v) \u00e0 la contamination, (vi) aux probl\u00e8mes de transport, et, le cas \u00e9ch\u00e9ant, quelles ont \u00e9t\u00e9 les conclusions relatives \u00e0 chaque risque; d) Sant\u00e9 Canada ou le ministre de la Sant\u00e9 ont-ils re\u00e7u des avertissements ou de la correspondance indiquant ou sugg\u00e9rant que cette pratique a cours au Canada, et, le cas \u00e9ch\u00e9ant, quels sont les d\u00e9tails, y compris (i) la date, (ii) l\u2019auteur de l\u2019avertissement ou de la correspondance, (iii) le r\u00e9sum\u00e9 de l\u2019avertissement ou de la correspondance, (iv) le destinataire, (v) le r\u00e9sum\u00e9 de la r\u00e9ponse donn\u00e9e par Sant\u00e9 Canada ou le cabinet du ministre; e) pour chaque avertissement ou correspondance re\u00e7u en d), quelle mesure de suivi a \u00e9t\u00e9 prise?</p>"
},
"url": "/debates/2022/11/21/stephen-ellis-1/",
"politician_url": "/politicians/stephen-ellis/",
"politician_membership_url": "/politicians/memberships/4645/",
"procedural": false,
"source_id": "p7438232",
"h1": {
"en": "Routine Proceedings",
"fr": "Affaires courantes"
},
"h2": {
"en": "Questions Passed as Orders for Returns",
"fr": "Questions transform\u00e9es en ordres de d\u00e9p\u00f4t de document"
},
"h3": {
"en": "Question No.857\u2014",
"fr": "Question no 857 \u2014"
},
"document_url": "/debates/2022/11/21/",
"related": {
"document_speeches_url": "/speeches/?document=%2Fdebates%2F2022%2F11%2F21%2F"
}
}